Other OTC - Delayed Quote • USD
Neutra Corp. (NTRR)
At close: April 25 at 3:15 PM EDT
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
Total Revenue
17.3970
67.9960
92.0140
9.6870
Cost of Revenue
9.3680
32.6900
60.8530
42.9440
Gross Profit
8.0290
35.3060
31.1610
-33.2570
Operating Expense
261.5230
332.9810
614.7430
445.4080
Operating Income
-253.4940
-297.6750
-583.5820
-478.6650
Net Non Operating Interest Income Expense
-18.0210
-62.0630
-60.6060
-121.6480
Other Income Expense
--
-198.1560
11.2620
61.4210
Pretax Income
-469.6710
-557.8940
-632.9260
-538.8920
Tax Provision
4.1610
3.5230
--
--
Net Income Common Stockholders
-474.9720
-576.8620
-742.1880
-580.6920
Diluted NI Available to Com Stockholders
-474.9720
-576.8620
-742.1880
-580.6920
Basic EPS
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
2,775,368.7420
2,230,594.1120
1,599,716.6160
1,192,972.5930
Diluted Average Shares
2,775,368.7420
2,230,594.1120
1,599,716.6160
1,192,972.5930
Total Operating Income as Reported
-253.4940
-297.6750
-583.5820
-478.6650
Total Expenses
270.8910
365.6710
675.5960
488.3520
Net Income from Continuing & Discontinued Operation
-473.8320
-561.4170
-632.9260
-538.8920
Normalized Income
-473.8320
-561.4170
-644.1880
-538.8920
Interest Expense
18.0210
62.0630
60.6060
121.6480
Net Interest Income
-18.0210
-62.0630
-60.6060
-121.6480
EBIT
-451.6500
-495.8310
-572.3200
-417.2440
EBITDA
-390.1070
-416.9250
-494.5350
-386.5780
Reconciled Cost of Revenue
9.3680
32.6900
60.8530
42.9440
Reconciled Depreciation
61.5430
78.9060
77.7850
30.6660
Net Income from Continuing Operation Net Minority Interest
-473.8320
-561.4170
-632.9260
-538.8920
Total Unusual Items Excluding Goodwill
--
--
11.2620
61.4210
Total Unusual Items
--
--
11.2620
61.4210
Normalized EBITDA
-390.1070
-416.9250
-505.7970
-386.5780
Tax Rate for Calcs
0.0002
0.0002
--
--
1/31/2021 - 10/12/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTLW Artelo Biosciences, Inc.
0.0118
-39.80%
ENSCW Ensysce Biosciences, Inc.
0.0300
0.00%
ARTL Artelo Biosciences, Inc.
1.3400
+1.52%
XRTX XORTX Therapeutics Inc.
2.5900
-13.09%
TXTM ProText Mobility, Inc.
0.0018
-21.74%
CELZ Creative Medical Technology Holdings, Inc.
4.4000
-8.81%
INKT MiNK Therapeutics, Inc.
0.8712
-2.00%
TVGN Tevogen Bio Holdings Inc.
0.8500
-43.33%
KZR Kezar Life Sciences, Inc.
0.7900
-1.42%
BYSI BeyondSpring Inc.
2.2700
-6.58%